Mackenzie A. Roof

Mackenzie A. Roof

Auto-generated profile, based on publicly available information

Mackenzie A. Roof

Department of Orthopedic Surgery, NYU Langone Health, New York, New York

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in JBJS Open Access
Verified
Journal Article
Open access
ISIttai Aviv Sourasky Medical Shichman
Ittai Aviv Sourasky Medical Shichman
MRMackenzie Roof
Mackenzie Roof
NANeil Askew
Neil Askew
LNLeo Nherera
Leo Nherera
JRJoshua C Rozell
Joshua C Rozell
RSRan Schwarzkopf
Ran Schwarzkopf
Background: National projections of future joint arthroplasties are useful for understanding the changing burden of surgery and related outcomes on the health system. The aim of this study is to update the literature by producing Medicare projections for primary total joint arthroplasty (TJA) procedures until 2040 and 2060. Methods: The present study used data from the Centers for Medicare & Medicaid Services (CMS) Medicare/Medicaid Part B National Summary and combined procedure counts with use of Current Procedural Terminology (CPT) codes to identify whether the procedure was a primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) procedure. In 2019, the annual volume of primary TKA was 480,958 and that of primary THA was 262,369. These values formed a baseline from which we generated point forecasts for 2020-2060 and 95% forecast intervals (FIs). Results: Between 2000 and 2019, the estimated annual volume of THA increased by 177% and that of TKA increased by 156% on average. Regression analysis projected an annual growth rate of 5.2% for THA and 4.44% for TKA. Based on these yearly projected increases, an estimated increase of 28.84% and 24.28% is expected for each 5-year period after 2020 for THA and TKA, respectively. By 2040, the number of THAs is projected to be 719,364 (95% FI, 624,766 to 828,286) and the number of TKA is projected to be 1,222,988 (95% FI, 988,714 to 1,512,772). By 2060, the number of THAs is projected to be 1,982,099 (95% FI, 1,624,215 to 2,418,839) and the number of TKAs is projected to be 2,917,959 (95% FI, 2,160,951 to 3,940,156). In 2019, Medicare data showed that THA constituted approximately 35% of TJA procedures performed. Conclusions: Based on 2019 total volume counts, our model forecasts an increase in THA procedures of 176% by 2040 and 659% by 2060. The estimated increase for TKA is projected to be 139% by 2040 and 469% by 2060. An accurate projection of future primary TJA procedure demands is important in order to understand future health-care utilization and surgeon demand. This finding is only applicable to a Medicare population and demands further analysis to see if this extends to other population groups. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 June 2021 in The Bone & Joint Journal
Verified
Journal Article
Closed access
MRMackenzie A. Roof
Mackenzie A. Roof
MSMohamad Sharan
Mohamad Sharan
DMDavid Merkow
David Merkow
JFJames E. Feng
James E. Feng
WLWilliam J. Long
William J. Long
RSRan S. Schwarzkopf
Ran S. Schwarzkopf
Aims: It has previously been shown that higher-volume hospitals have better outcomes following revision total knee arthroplasty (rTKA). We were unable to identify any studies which investigated the effect of surgeon volume on the outcome of rTKA. We sought to investigate whether patients of high-volume (HV) rTKA surgeons have better outcomes following this procedure compared with those of low-volume (LV) surgeons. Methods: This retrospective study involved patients who underwent aseptic unilateral rTKA between January 2016 and March 2019, using the database of a large urban academic medical centre. Surgeons who performed ≥ 19 aseptic rTKAs per year during the study period were considered HV and those who performed < 19 per year were considered LV. Demographic characteristics, surgical factors, and postoperative outcomes were compared between the two groups. Results: A total of 308 rTKAs were identified, 132 performed by HV surgeons and 176 by 22 LV surgeons. The LV group had a significantly greater proportion of non-smokers (59.8% vs 49.2%; p = 0.029). For all types of revision, HV surgeons had significantly shorter mean operating times by 17.75 minutes (p = 0.007). For the 169 full revisions (85 HV, 84 LV), HV surgeons had significantly shorter operating times (131.12 (SD 33.78) vs 171.65 (SD 49.88) minutes; p < 0.001), significantly lower re-revision rates (7.1% vs 19.0%; p = 0.023) and significantly fewer re-revisions (0.07 (SD 0.26) vs 0.29 (SD 0.74); p = 0.017). Conclusion: Patients of HV rTKA surgeons have better outcomes following full rTKA. These findings support the development of revision teams within arthroplasty centres of excellence to offer patients the best possible outcomes following rTKA. Cite this article: Bone Joint J 2021;103-B(6 Supple A):131–136.

1 December 2021 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MRMackenzie A. Roof
Mackenzie A. Roof
KLKatherine Lygrisse
Katherine Lygrisse
LKLauren Keitel
Lauren Keitel
ASAhmed Siddiqi
Ahmed Siddiqi
AEAhmed Emara
Ahmed Emara
NBNicholas A. Bedard
Nicholas A. Bedard

18 June 2022 in Knee Surgery & Related Research
Verified
Journal Article
Open access
PDF file
MRMackenzie A. Roof
Mackenzie A. Roof
JKJason B. Kreinces
Jason B. Kreinces
RSRan Schwarzkopf
Ran Schwarzkopf
JRJoshua C. Rozell
Joshua C. Rozell
VAVinay K Aggarwal
Vinay K Aggarwal
Introduction: Surgeons can improve their practice by understanding potentially avoidable reasons for early revision total knee arthroplasty (rTKA). The purpose of this study is to describe potentially avoidable indications for rTKA within 5 years of the index procedure. Methods: This retrospective observational analysis utilized the rTKA database at a large, academic orthopedic specialty hospital to identify 167 consecutive rTKA from 2014 to 2019 performed within 5 years after primary TKA (pTKA). Two fellowship-trained arthroplasty surgeons reviewed the cases to classify them as potentially avoidable or unavoidable. Unavoidable indications for rTKA included infection/wound complication, arthrofibrosis, instability due to underlying collagen disease or significant weight loss, and any traumatic event leading to pTKA failure. Potentially avoidable indications included atraumatic instability, intraoperative fracture, metal allergy, and atraumatic patellar instability or maltracking. Aseptic loosening was considered avoidable if it occurred in the presence of component malpositioning or poor cementation technique. Results: There were 112 (67.1%) unavoidable cases and 55 avoidable cases (32.9%). Of the unavoidable cases, there were 68 rTKA for infection or wound complications (60.7%), 23 for arthrofibrosis (20.5%), 6 for instability (5.4%), 6 for postoperative fracture (5.4%), 6 for aseptic loosening (5.4%), and 3 for extensor mechanism pathology following trauma (2.6%). Of the potentially avoidable rTKA, 24 were for aseptic loosening (43.7%), 23 for atraumatic instability (41.8%), 6 for atraumatic extensor mechanism pathology (10.9%), 1 for nickel allergy (1.8%), and 1 for intraoperative fracture (1.8%). Conclusion: These findings indicate that over 30% of early rTKA are potentially avoidable. Interventions should focus on addressing potentially avoidable causes such as short-term aseptic loosening and instability to reduce the need for costly and resource-intensive rTKA. Level of evidence III, retrospective observational analysis

1 September 2019 in JBJS Reviews
Verified
Journal Article
Closed access
IFIsabella M. Ferre
Isabella M. Ferre
MRMackenzie A. Roof
Mackenzie A. Roof
AAAfshin A. Anoushiravani
Afshin A. Anoushiravani
AWAmy S. Wasterlain
Amy S. Wasterlain
CLClaudette M. Lajam
Claudette M. Lajam
» When stratified by sex and age, there is a greater age-adjusted prevalence of osteoarthritis in women (23.5%) as compared with men (18.1%). » The discrepancy between males and females in the prevalence of osteoarthritis is likely multifactorial, being related to hormonal, metabolic, structural, and nutritional differences. » Cartilage is lost at a higher rate in women after accounting for confounding variables such as age, body mass index, and bone volume at baseline. » Estrogen replacement therapy diminishes the expression of pro-inflammatory cytokines and reduces the prevalence of osteoarthritis in animal models and humans. » Much work remains to understand the etiology of the sex gap seen in degenerative joint disease.

23 October 2023 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
KLKyle W. Lawrence
Kyle W. Lawrence
HRHayley E. Raymond
Hayley E. Raymond
CSChelsea S. Sicat
Chelsea S. Sicat
MRMackenzie A. Roof
Mackenzie A. Roof
AAArmin Arshi
Armin Arshi
RSRan Schwarzkopf
Ran Schwarzkopf